Search Results

Filter
  • 1-10 of  156 results for ""MALARIA vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Genetic diversity of Plasmodium falciparum reticulocyte binding protein homologue-5, which is a potential malaria vaccine candidate: baseline data from areas of varying malaria endemicity in Mainland Tanzania.

  • Authors : Kisambale AJ; National Institute for Medical Research, Dar Es Salaam, Tanzania.; Pereus D

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/genetics ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Genetic Variation*

  • Source: Malaria journal [Malar J] 2025 Jan 27; Vol. 24 (1), pp. 29. Date of Electronic Publication: 2025 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Naturally acquired IgG responses to Plasmodium falciparum do not target the conserved termini of the malaria vaccine candidate Merozoite Surface Protein 2.

  • Authors : Zerebinski J; Division of Infectious Diseases, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/immunology ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/blood

  • Source: Frontiers in immunology [Front Immunol] 2024 Dec 09; Vol. 15, pp. 1501700. Date of Electronic Publication: 2024 Dec 09 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.

  • Authors : Silk SE; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.; Kalinga WF

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/administration & dosage ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/adverse effects

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Oct; Vol. 24 (10), pp. 1105-1117. Date of Electronic Publication: 2024 Jun 13.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults.

  • Authors : Tumbo A; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/administration & dosage ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology

  • Source: EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105364. Date of Electronic Publication: 2024 Sep 30.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.

  • Authors : Jun H; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.; Mazigo E

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 18; Vol. 15, pp. 1495513. Date of Electronic Publication: 2024 Nov 18 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Designing and deploying caller tunes on mobile phones to promote malaria vaccine uptake in Africa: can the technology acceptance model (TAM) help?

  • Authors : Eneh S; Department of Community Health, Obafemi Awolowo University, Ile-Ife, Osun, Nigeria. .; Ivan Research Institute, University of Nigeria, Enugu, Nigeria. .

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/administration & dosage ; Cell Phone*; Humans

  • Source: Malaria journal [Malar J] 2024 Nov 02; Vol. 23 (1), pp. 325. Date of Electronic Publication: 2024 Nov 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/complications ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/prevention & control

  • Source: The Journal of clinical investigation [J Clin Invest] 2024 Jan 09; Vol. 134 (6). Date of Electronic Publication: 2024 Jan 09.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

  • Authors : Silk SE; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, UK; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford OX3 7LE, UK

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/adverse effects ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/prevention & controlchimpanzee adenovirus serotype 63

  • Source: Med (New York, N.Y.) [Med] 2023 Oct 13; Vol. 4 (10), pp. 668-686.e7. Date of Electronic Publication: 2023 Aug 11.Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Understanding the role of serological and clinical data on assessing the dynamic of malaria transmission: a case study of Bagamoyo district, Tanzania.

  • Authors : Mwamlima TG; Ifakara Health Institute, Bagamoyo, Tanzania.; Department of Life Science and Bio-Engineering, The Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.

Subjects: Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/epidemiology ; Malaria Vaccines* ; Malaria*/Malaria*/Malaria*/epidemiology

  • Source: The Pan African medical journal [Pan Afr Med J] 2022 Oct 07; Vol. 43, pp. 60. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.

  • Authors : Tumbo AM; Department of Intervention and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.; Department of Medical Parasitology and Infection Biology, Clinical Immunology Unit, Swiss Tropical and Public Health Institute, Socinstr. 57, 4002, Basel, Switzerland.

Subjects: Coinfection/Coinfection/Coinfection/*immunology ; Flaviviridae Infections/Flaviviridae Infections/Flaviviridae Infections/*immunology ; Malaria Vaccines/Malaria Vaccines/Malaria Vaccines/*immunology

  • Source: Virology journal [Virol J] 2021 Jan 26; Vol. 18 (1), pp. 28. Date of Electronic Publication: 2021 Jan 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

×
  • 1-10 of  156 results for ""MALARIA vaccines""